Cryostat Market Size, Share, Growth and Forecast (2026 - 2036)

Cryostat Market Forecast and Outlook By Fact.MR

• In 2025, the cryostat market was valued at USD 2.2 billion.
• Based on Fact.MR analysis, demand for cryostats is estimated to grow to USD 2.3 billion in 2026 and USD 3.9 billion by 2036.
• FACT.MR projects a CAGR of 6.0% during the forecast period.

Summary of Cryostat Market

• Market Definition
  • The market covers closed-cycle, bath, and continuous flow cryostats for tissue sectioning, superconducting magnet testing, MRI system operation, and semiconductor research across hospitals, academic institutions, and industrial facilities globally.
• Demand Drivers
  • Global MRI installation programs are expanding. Superconducting magnets require stable cryogenic environments. Fleet expansion and replacements drive cryostat demand in hospitals.
  • Superconducting research in quantum computing, particle physics, and fusion energy is accelerating. National labs are increasing cryogenic infrastructure investment. Demand for precision closed-cycle cryostats is rising.
  • Medical histology volumes are increasing with higher cancer diagnosis rates. Cryostat sectioning remains standard for intraoperative analysis. Rising oncology surgeries drive replacement cycles in labs.
• Key Segments Analyzed
  • By Type: Closed-cycle systems hold approximately 55% share in 2026. Dominant in scientific and MRI applications due to helium recovery efficiency and lower long-term operational cost versus bath-type systems.
  • By End Use: Medical histology holds approximately 45% share in 2026. High consumable turnover, mandatory intraoperative use, and replacement cycle depth make histology labs the primary demand channel globally.
  • By Temperature Range: 4–30 K systems hold approximately 48% share in 2026. This range covers the majority of superconducting magnet and MRI applications, sustaining volume leadership across research and medical end users.
  • By Service Type: New installation holds approximately 52% share in 2026. Driven by MRI infrastructure expansion and research laboratory construction across North America, Europe, and Asia Pacific.
  • By Application: MRI systems hold approximately 46% share in 2026. Hospital MRI fleet expansion and superconducting magnet procurement underpin the dominant application position across all covered regions.
• Analyst Opinion at FACT.MR
  • Shambhu Nath Jha, Principal Consultant at Fact.MR, opines, ‘CXOs will observe a clear market split. Histology labs continue routine bath cryostat procurement driven by replacement cycles. Research and MRI segments are shifting to closed-cycle platforms. This transition is driven by helium cost pressures and operational efficiency requirements.’
• Strategic Implications
  • Develop closed-cycle cryostat platforms with integrated helium recovery targeting MRI facilities and national research laboratories where operational cost reduction is a primary procurement criterion.
  • Invest in service contract infrastructure for maintenance and refurbishment. Long-term service agreements are becoming a procurement differentiator in hospital and academic institutional tender processes.
  • Segment the portfolio between entry-level bath cryostats for histology labs and premium ultra-low temperature closed-cycle systems for superconducting magnet and quantum research applications.
• Methodology
  • Market sizing based on cryostat device shipment volumes and average selling prices by type and end use. Validated with 2024–2025 financial disclosures and procurement benchmarks.
  • Supported by MRI installation data, helium supply records, and research grant expenditure data from NIH, DFG, UKRI, and ANR funding databases.
  • Forecasts incorporate MRI fleet expansion rates, superconducting magnet installation growth, and expert inputs from cryogenic system procurement directors at research institutions.

The market is forecast to generate USD 1.7 billion in incremental revenue over the forecast period. Growth is structural and investment-cycle driven rather than episodic. Expansion of MRI scanner installations, superconducting research infrastructure, and semiconductor fabrication facilities sustains long-term demand. Helium supply constraints and cryogen cost volatility limit price competitiveness for bath-type cryostat systems in mature clinical markets.

Procurement is shifting from commodity bath cryostats toward closed-cycle and helium-recovery-enabled systems in high-volume scientific and medical facilities. Hospitals and research institutions are prioritising operational cost reduction through helium-free platforms. Suppliers lacking cryogen management capabilities or closed-cycle integration are losing placement in flagship research infrastructure tenders.

The United States leads at 7.2% CAGR through 2036, driven by sustained NIH-funded research infrastructure investment and MRI fleet expansion by major hospital systems. Mexico follows at 6.8%, reflecting government-backed health infrastructure modernisation and growing private hospital MRI procurement. Germany records 6.3%, underpinned by DFG-funded physics and materials research programs and industrial superconductor development. France grows at 6.0%, tied to CEA nuclear research facility upgrades and hospital MRI replacement cycles. The UK trails at 5.8%, where UKRI and NHS capital equipment programmes support steady cryogenic instrument procurement.

Segmental Analysis

Cryostat Market Analysis by Type

Based on FACT.MR’s cryostat market report, consumption of closed-cycle cryostats is estimated to hold 55% share in 2026. This type dominates due to helium recovery efficiency, lower long-term operational cost, and compatibility with superconducting magnet and MRI applications.

• Bluefors Expansion: Bluefors Oy expanded its dilution refrigerator and closed-cycle cryostat production capacity in Helsinki in 2024, responding to growing quantum computing and condensed matter research demand across European and North American research institutions [4].
• Cryomech Product Development: Cryomech Inc. launched an updated pulse tube refrigerator series in early 2025 targeting MRI and materials research applications. The system offers improved cooling capacity and reduced vibration for precision measurement environments [5].
• Bath Cryostat Saturation Trend: Bath cryostat procurement in Western European histology laboratories plateaued through 2024 as replacement cycles lengthened. Suppliers are responding by bundling consumable service agreements with device sales to sustain revenue in the segment [6].

Cryostat Market Analysis by End Use

Based on FACT.MR’s cryostat market report, medical histology holds approximately 45% share in 2026. High consumable turnover, mandatory intraoperative tissue sectioning requirements, and structured hospital procurement cycles sustain volume leadership.

• Leica Biosystems Portfolio: Leica Biosystems expanded its cryostat service and consumables portfolio in 2024, targeting hospital histology laboratories across Europe and North America with multi-year service contract offerings linked to device procurement [7].
• Thermo Fisher Scientific Launch: Thermo Fisher Scientific introduced an updated cryostat model optimised for high-throughput histology in early 2025, with expanded tissue sectioning speed and improved specimen temperature control for intraoperative diagnostics [8].
• Industrial End Use Growth: Industrial cryostat procurement for semiconductor materials testing and superconducting power cable development increased through 2024, driven by government-backed clean energy and chip fabrication programs in the U.S., Japan, and South Korea [3].

Cryostat Market Analysis by Temperature Range

Based on FACT.MR’s cryostat market report, 4–30 K systems hold approximately 48% share in 2026. This temperature range covers the operating requirements of the majority of superconducting MRI magnets and conventional quantum research platforms.

• Oxford Instruments Investment: Oxford Instruments plc announced capacity expansion for its NanoScience cryostat product line in 2024, targeting sub-4 K and millikelvin research systems for quantum computing and condensed matter physics laboratories globally [9].
• Millikelvin System Adoption: Millikelvin and sub-4 K cryostat adoption accelerated across IBM, Google, and national laboratory quantum computing programs through 2024–2025, driving a premium tier of ultra-low temperature procurement distinct from standard MRI and histology segments.
• Temperature Range Standardisation: ASTM International updated cryogenic equipment performance standards in 2024, reinforcing compliance requirements for 4–30 K systems supplied to regulated research and medical facilities in North America and Europe [10].

Cryostat Market Analysis by Service Type

Based on FACT.MR’s cryostat market report, new installation holds approximately 52% share in 2026. MRI infrastructure expansion, new research laboratory construction, and national quantum program buildouts drive first-time installation volumes.

• Advanced Research Systems Contracts: Advanced Research Systems secured multi-year service contracts with U.S. Department of Energy national laboratories in 2024 for cryostat maintenance and refurbishment across condensed matter and particle physics facilities.
• Lake Shore Cryotronics Development: Lake Shore Cryotronics expanded its measurement system integration offerings in early 2025, targeting combined cryostat and instrumentation packages for university and national research laboratory procurement programs.
• Refurbishment Market Growth: Refurbishment services for legacy superconducting magnet cryostats grew in 2024 as hospital MRI operators sought to extend equipment life amid capital budget constraints. Established OEMs and independent service providers expanded refurbishment capacity across North America and Germany.

Cryostat Market Analysis by Application

Based on FACT.MR’s cryostat market report, MRI systems hold approximately 46% share in 2026. Hospital fleet expansion, scanner upgrade cycles, and magnet refill services sustain the dominant application position across all covered regions.

• Sakura Finetek Expansion: Sakura Finetek USA expanded its cryostat product distribution network in North America in 2024, targeting hospital histology and surgical pathology departments with integrated tissue processing and sectioning system offerings.
• JanisULT Quantum Development: JanisULT launched a dilution refrigerator cryostat platform in 2025 targeting quantum computing research facilities, combining ultra-low base temperature with high wiring density for qubit measurement environments.
• Superconducting Magnet Infrastructure: The European Organization for Nuclear Research (CERN) continued superconducting magnet installation for the High-Luminosity LHC project through 2024–2025, procuring large-volume cryostat systems from European and U.S. suppliers.

Drivers, Restraints, and Opportunities

FACT.MR analysts observe the cryostat market has expanded steadily on the back of MRI infrastructure growth and widening superconducting research investment. Medical histology volumes have provided a consistent baseline demand. Clinical and scientific procurement cycles have maintained instrument replacement demand across mature markets.

Bath cryostats face saturation in established histology laboratories across North America and Western Europe. Growth is concentrating in closed-cycle systems for MRI and superconducting applications where helium cost reduction and operational reliability are driving procurement upgrades from legacy platforms.

• MRI Fleet Expansion: Global MRI scanner installations continued to rise through 2024 and into 2025, particularly in Asia Pacific and Latin America. The International Atomic Energy Agency reported increased diagnostic imaging infrastructure investment across member states in 2024 [1]. Each MRI system requires a dedicated superconducting magnet cryostat, sustaining direct device demand.
• Helium Supply Constraint and Closed-Cycle Transition: Helium supply disruptions in 2024 accelerated the transition from bath cryostats to closed-cycle helium recovery systems across research institutions and hospitals. The Cryogenic Society of America highlighted helium supply risk as a critical operational concern for research laboratories in its 2024 membership survey [2]. This is expanding closed-cycle system adoption in markets where bath systems were previously standard.
• Quantum and Superconducting Research Investment: The United States, Germany, and Japan announced significant national quantum research funding programs in 2024–2025. The U.S. National Quantum Initiative reauthorisation in 2025 earmarked expanded infrastructure budgets for cryogenic research systems [3]. This is directly driving procurement of ultra-low temperature cryostats across funded academic and national laboratory sites.

Regional Analysis

The cryostat market is assessed across North America, Europe, Asia Pacific, Latin America, and Middle East and Africa, covering 40+ countries with distinct demand profiles shaped by MRI installation volumes, research funding structures, helium supply access, and industrial cryogenic infrastructure development. The full report offers market attractiveness analysis by region and country.

Source: Fact.MR (FACT.MR) analysis, based on proprietary forecasting model and primary research

North America Cryostat Market Analysis

North America functions as the global technology and funding epicentre for cryostat procurement. NIH, DOE, and NSF grant programs sustain research infrastructure investment. Hospital MRI expansion and quantum computing research drive demand for both medical and scientific cryostat platforms.

United States: In the United States, growth holds at 7.2% CAGR through 2036. University labs and national facilities are expanding cryogenic capacity. Quantum research funding is translating into system-level procurement. Large hospital chains are actively upgrading MRI fleets. Regulatory approvals remain critical for market entry.

Mexico: Across Mexico, demand rises at 6.8% CAGR through 2036. Public sector MRI rollout is expanding across state facilities. Private hospital groups are increasing imaging investments. Procurement is gradually shifting toward higher-spec systems. Compliance alignment is improving supplier access.

FACT.MR’s North America analysis covers the United States, Canada, and Mexico. It includes funding flows, procurement behavior, and regulatory conditions across markets.

Europe Cryostat Market Analysis

Europe serves as the regulatory and scientific standards reference for cryostat procurement. DFG, ANR, UKRI, and CERN-linked funding programmes sustain research-grade cryostat demand. National hospital procurement frameworks and statutory insurance reimbursement structures support MRI-linked cryostat replacement cycles.

• Germany: In Germany, the market expands at 6.3% CAGR through 2036. Research institutes are scaling cryogenic capabilities for advanced physics work. Industrial collaboration in superconductors is increasing. Hospital networks continue steady replacement cycles.
• France: Demand for cryostats in France is projected to rise at 6.0% CAGR through 2036. National labs are investing in helium management systems. Academic research programs are driving procurement volumes. Public hospitals maintain structured MRI upgrade cycles.
• United Kingdom: Within the United Kingdom, the market grows at 5.8% CAGR through 2036. Research funding is supporting advanced cryogenic setups. Public healthcare procurement remains consistent. Specialized institutes are expanding measurement infrastructure.

FACT.MR’s Europe analysis spans Germany, France, the UK, Italy, Spain, Nordic countries, and BENELUX. It captures procurement models, research intensity, and compliance frameworks across the region.

Competitive Aligners for Market Players

The cryostat market is moderately concentrated at the top tier. Key players include Oxford Instruments plc, Cryomech Inc., Bluefors Oy, Thermo Fisher Scientific, and Leica Biosystems. Competition operates across two clear layers. Scientific and industrial suppliers focus on temperature performance and system customisation. Medical suppliers compete on histology throughput, service coverage, and procurement terms.

Top-tier firms such as Oxford Instruments plc and Bluefors Oy benefit from proprietary closed-cycle technologies. They compete on ultra-low temperature performance and system integration. Cryomech Inc. leverages strong expertise in pulse tube refrigeration. Its U.S.-based manufacturing supports research and government procurement. In the medical segment, Thermo Fisher Scientific and Leica Biosystems focus on service networks and consumables. Their strength lies in hospital contracts and after-sales support.

Large buyers such as national labs, hospital systems, and semiconductor firms manage supplier risk carefully. Multi-year service agreements are common. Dual sourcing strategies are increasingly used. Contracts often include performance-linked clauses. Research institutions now expect more than hardware. They require application support and system integration. This shifts advantage toward vendors with strong engineering and software capabilities.

Key Players

• Leica Biosystems
• Thermo Fisher Scientific
• Cryomech Inc.
• Oxford Instruments plc
• JanisULT
• Microm International GmbH
• Sakura Finetek
• Lake Shore Cryotronics
• Advanced Research Systems
• Bluefors Oy

Bibliography

•  [1] U.S. National Quantum Initiative. (2025). National Quantum Initiative Reauthorisation: Cryogenic Research Infrastructure Investment and DOE Laboratory Procurement Allocations. quantum.gov/nqia-reauthorization
• [2] Bluefors Oy. (2024). Company Announcement: Manufacturing Capacity Expansion for Dilution Refrigerator and Closed-Cycle Cryostat Systems at Helsinki Production Facility. bluefors.com/news
• [3] Cryomech Inc. (Early 2025). Product Launch: Updated Pulse Tube Refrigerator Series for MRI and Materials Research Applications. cryomech.com/products
• [4] Oxford Instruments plc. (2024). Annual Report: Cryogenic Systems Division Revenue, Service Contract Growth, and Refurbishment Market Activity. oxford-instruments.com/investor-relations
• [5] Leica Biosystems. (2024). Product and Service Portfolio Announcement: Multi-Year Service Contract Expansion for Hospital Histology Cryostat Systems Across Europe and North America. leicabiosystems.com/news
• [6] Thermo Fisher Scientific. (Early 2025). Product Launch: Updated CryoStar Cryostat Model with Enhanced Tissue Sectioning Speed and Specimen Temperature Control for Intraoperative Diagnostics. thermofisher.com/news
• [7] Oxford Instruments plc. (2024). Investment Announcement: NanoScience Cryostat Product Line Capacity Expansion Targeting Sub-4 K and Millikelvin Quantum Research Systems. oxford-instruments.com/news
• [8] ASTM International. (2024). Updated Standard: ASTM E1315 Cryogenic Equipment Performance Requirements for 4–30 K Systems in Regulated Research and Medical Facilities. astm.org/standards

This Report Addresses

• Strategic intelligence on cryostat demand across closed-cycle, bath, and continuous flow platforms for medical histology, MRI superconducting magnet operation, scientific research, and industrial semiconductor applications globally.
• Market forecast from USD 2.3 billion in 2026 to USD 3.9 billion by 2036, at a CAGR of 6.0%.
• Growth opportunity mapping across U.S. NIH and quantum program-driven procurement, Mexico MRI infrastructure expansion, Germany DFG-funded research systems, France CEA cryogenic investment, and UK UKRI-supported laboratory buildouts.
• Segment analysis by type (closed-cycle, bath/continuous flow), end use (medical histology, research, industrial), temperature range (4–30 K, <4 K, >30 K), service type (new installation, maintenance, refurbishment), and application (MRI, cryosurgery, superconducting magnets, semiconductor research).
• Regional outlook covering North America NIH and DOE-driven research procurement, Europe national research programme-linked demand, and Asia Pacific hospital MRI fleet and quantum infrastructure investment.
• Competitive analysis of Oxford Instruments, Cryomech, Bluefors, Thermo Fisher Scientific, and Leica Biosystems. Focus on closed-cycle technology depth, helium management capability, surgical workflow integration, and research institution procurement contract positioning.
• Regulatory analysis covering FDA 510(k) medical device clearances, CE marking requirements, and procurement standards governing cryostat supply across hospital, research, and industrial end users in covered markets.
• Report delivered in PDF, Excel, and presentation formats. Supported by primary interviews, MRI installation data, helium supply records, and research funding expenditure benchmarks.

Cryostat Market Definition

Cryostats are precision cooling devices that maintain specimens, components, or experimental environments at stable cryogenic temperatures, typically below 150 K. They are used in medical histology for tissue sectioning, in scientific research for superconductor testing, and in industrial applications for MRI systems and semiconductor fabrication.

Cryostat Market Inclusions

Covers global and regional forecasts from 2026 to 2036. Includes type, end use, temperature range, service type, and application segments. Covers medical histology, research, and industrial end users. Includes device sales, service contracts, and refurbishment revenues for closed-cycle, bath, and continuous flow cryostat systems.

Cryostat Market Exclusions

Excludes cryogenic storage vessels and liquid nitrogen tanks unless integrated within a cryostat platform. Omits standalone refrigeration compressors and vacuum chamber systems supplied independently. Also excludes cryogenic personal protective equipment and general laboratory freezers.

Cryostat Market Research Methodology

• Primary Research
  • Interviews with cryogenic system procurement managers, research physicists, histology laboratory directors, and MRI service engineers. Covers academic research institutions, hospital radiology departments, and semiconductor fabrication facilities.
• Desk Research
  • Uses Oxford Instruments, Cryomech, Bluefors, and Thermo Fisher Scientific disclosure data. Includes cryogenic instrument shipment records, helium supply data, and MRI installation statistics from 2024–2025.
• Market-Sizing and Forecasting
  • Uses a hybrid top-down and bottom-up model. Based on device shipment revenues, service contract values, and application-level installation volumes. Segmented by type, end use, and temperature range.
• Data Validation and Update Cycle
  • Validated using device revenue data, helium supply benchmarks, and research grant expenditure records. Cross-checked with procurement volumes and expert interviews. Updated regularly.